Results 61 to 70 of about 7,837 (201)

Management of a twin pregnancy patient with Glanzmann thrombasthenia might be caused by a novel ITGA2B gene mutation (c.2822G>A): a case report and family investigation

Platelets
Mutations in the ITGA2B or ITGB3 gene that encodes for the αIIbβ3 platelet integrin usually cause Glanzmann thrombasthenia (GT). This study aims to investigate the clinical characteristics of a pedigree exhibiting an inherited hemorrhagic disorder ...
Xiangcheng Liao, Ruikai Zhu, Zhigang Yang, Aiqiu Qin, Yucong Huang, Ping Li, Liling Liu, Zhuning Mo   +7 more
doaj   +1 more source

A sound vision: MYO7A gene therapy reaches the inner ear

The Journal of Physiology, Volume 603, Issue 22, Page 6673-6674, November 15, 2025.
Shahar Taiber, Karen B. Avraham
wiley   +1 more source

Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions

The Turkish Journal of Pediatrics, 2003
Transfusion of platelet concentrates remains the first-line therapy for Glanzmann thrombasthenia in case of bleeding or preparation for surgery. However, development of antibodies to platelet glycoprotein (Gp) IIb/IIIa complex or human leukocyte ...
Omer Devecioğlu, Ayşegül Unüvar, Sema Anak, Ilmay Bilge, Haluk Ander, Orhan Ziylan   +5 more
doaj  

A Patient with a Prolonged Activated Partial Thromboplastin Time and a Deep Intracerebral Haemorrhage

Case Reports in Neurology, 2012
We report on a 57-year-old woman with a pontine haemorrhage and an extremely prolonged activated partial thromboplastin time (aPTT) of more than 240 s, suggestive of a coagulation disorder.
Roger K. Schindhelm, Mariëlle J. Wondergem, Joke Admiraal, Gert Nap, Edwin ten Boekel, Lahcen Hani   +5 more
doaj   +1 more source

Use of Recombinant Activated Factor VIIa in a Six-Month-Old Child Due to Massive Hemorrhage During Elective Surgery for Choroid Plexus Carcinoma: Case Report

Acta Clinica Croatica, 2015
We present the use of recombinant activated factor VIIa (rFVIIa) in a 6-month-old infant that suffered massive bleeding and subsequent coagulation disturbances during elective surgery for choroid plexus carcinoma in the lateral ventricle.
Alenka Spindler Vesel, Vesna Novak-Jankovič, Branka Maldini, Neva Požar Lukanović, Kata Denić, Jasmina Markovič-Božič, Maja Šoštarič   +6 more
doaj  

Emergency cesarean section in glanzmann thrombasthenia: Anaesthetic management without recombinant factor VIIa. [PDF]

Saudi J Anaesth, 2023
Priyanka A, Arulprakasam S, Rudingwa P.
europepmc   +1 more source

Pregnant Women with Severe Factor VII Deficiency Undergoing Cesarean Section Managed with a Short-Term Regimen of Recombinant Factor VIIa. [PDF]

Matern Fetal Med, 2023
Obore N, Jin W, Huiqin Q, Wei Q, Yan H, Hong Y.   +5 more
europepmc   +1 more source

Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors [PDF]

, 2002
Niamh O’Connell, Corrina Mc Mahon, Jude Smith, Kate Khair, Ian Hann, Ri Liesner, Owen Smith   +6 more
openalex   +1 more source

Patient with congenital factor VII deficiency undergoing brain tumor neurosurgery successfully treated with recombinant factor VIIa and fresh frozen plasma: A case report and literature review. [PDF]

Medicine (Baltimore), 2023
Huang C, Yu Y, Zhai N, Mo W, Lin F.
europepmc   +1 more source

Post-operative Bleeding due to Acquired Hemophilia Successfully Treated with Recombinant Factor VIIa: Case Report [PDF]

, 2009
Naria Lee, Seong Hoon Yoon, Won Lim, Mi‐Hyun Kim, Hyo Jeong Kim, Seon Kyeong Kim, Jin Sup Park, Young Mi Seol, Gyung Hyuck Ko, Young Jin Choi, Joo Seop Chung, Goon Jae Cho   +11 more
openalex   +1 more source